Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial

Table 4 Results of repeated-measures ANOVA (group × time) tests for outcome measures at pre- and post-tests (N = 110)

AT: Adherence Therapy, ARS: Adherence Rating Scale; possible score range 1 to 5, with higher scores indicating better adherence to medication, ITAQ: Insight and Treatment Attitudes Questionnaire; possible score range from 0 to 22, with higher scores indicating better insight, PANSS: Positive and Negative Syndrome Scale; possible score range from 30 to 210, with higher scores indicating greater severity of symptoms; the possible scores of Positive and Negative Symptoms subscales range from 7 to 49, SLOF: Specific Levels of Functioning scale; possible score range from 43 to 215, with higher scores indicating higher level of psychosocial and self-care functioning, TAU: Treatment as usual, T0: Baseline measure at recruitment, T1: First post-test at immediately after completion of the interventions, T2: Second post-test at six months after interventions
^a Average number of readmissions to a psychiatric hospital or inpatient unit over the past four months, ^b Duration of readmissions to a psychiatric hospital or inpatient unit in terms of average number of days of hospital stay over four months. ^cF values (group × time) for repeated-measures ANOVA test, df = 1,109

ISSN: 1745-6215